Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Melanoma|Neoplasm Metastasis
Interventions: DRUG: gp100:209-217 (210M)|DRUG: Montanide ISA-51|DRUG: IL-2|DRUG: MART-1:26-35(27L)|BIOLOGICAL: Abl cells|DRUG: Fludarabine|DRUG: Cyclophosphamide|BIOLOGICAL: GCSF (Growth colony stimulating factor)|PROCEDURE: Apheresis
Sponsor: National Cancer Institute (NCI)